This new position paper proposes 5 pre-defined business priorities to help pharma affiliates adjust to the changes of HCPs expectations, so that to keep them engaged in the post-Covid-19 era.
News
This position paper provides insights regarding Pharma Corporate Strategy and address the following key issues:
This position paper provides five marketing solutions to address specific challenges faced by pharma companies: These five...
This position paper evaluates the distribution alternatives for high-priced drugs on the French retail pharma market, based...